Press Releases
Aledade Announces Carbon Neutrality, Additional Sustainability Efforts
On Earth Day 2021, Aledade announced three key sustainability commitments the company is making in an effort to reduce its carbon footprint and support a healthier environment. First among them, Aledade announced that, effective immediately, the company is carbon-neutral and will ensure the offset of any carbon...
Evidation Partners with HealthVerity to Enhance its Research and Virtual Health Offerings
Evidation and HealthVerity have announced a collaboration to provide greater transparency to the patient experience by allowing individuals to connect their wearable and survey data with real-world data from clinical settings via HealthVerity. The partnership will enable researchers and developers of health programs...
Clinical Ink Deploys eCOA Solutions for Industry’s Most Complex Assessments
Global clinical trial technology company Clinical Ink announced that it has deployed an industry-leading 500 unique eCOA scales and assessments in 82 languages. eCOA, or electronic clinical outcome assessment, instruments play a critical role in clinical trial conduct and are used in a variety of ways, from screening...
Health Care Transformation Task Force Expands its Executive Committee
Aledade Chief Commercial Officer and Chief Policy Officer Sean Cavanaugh is one of five people recently elected to the Executive Committee of the Health Care Transformation Task Force. The Health Care Transformation Task Force (HCTTF) is a group of leading payers, providers, purchasers, and patient advocacy...
Accolade to Announce Fiscal Fourth Quarter and Full Year 2021 Financial Results
Accolade, which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, announced that it will release fiscal fourth quarter and full year 2021 financial results on Wednesday, May 5, 2021, after the market...
Evidation Raises $153 Million to Scale Virtual Health Capabilities of Achievement™ Platform
Evidation Health today announced the close of a $153 million Series E growth funding round to rapidly expand its virtual health programs on Achievement, the largest digital health network in the United States. The round was co-led by OMERS Growth Equity and Kaiser Permanente Group Trust; existing investors including...
CD&R, Merck, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Platform
Oncology data and informatics platform M2GEN has announced a significant investment by three major venture investment firms: Clayton, Dubilier & Rice (CD&R), Merck Global Health Innovation Fund (Merck GHI), and McKesson Ventures. The investment will recapitalize M2GEN to accelerate the growth of M2GEN’s...
GRAIL, AccessHope Collaborate to Optimize Patient and Healthcare Provider Experience for Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test
GRAIL has announced that it is joining forces with AccessHope™ to offer a world-class service experience to people who use Galleri™, GRAIL’s first-of-kind multi-cancer early detection blood test. This collaboration is part of GRAIL’s effort to help patients and their healthcare providers achieve favorable outcomes by...
GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Test
GRAIL today announced a partnership with the health system Providence to offer Galleri, GRAIL’s multi-cancer early detection blood test. Providence, based in Renton, Wash., will offer Galleri as a complement to recommended single cancer screening tests. Providence will initially deploy Galleri at its California,...
Truveris Expands Leadership Team With Key Appointments
Truveris, a digital health company focused on reducing costs and improving access in pharmacy, announced that it has bolstered its leadership team with several key hires and internal appointments. Under the leadership of CEO Jeff Eberle, Truveris has assembled a seasoned team of industry veterans to drive innovation...
Other News
New multi-cancer early detection blood test study opens
The University of Oxford has opened a new study, which will trial a new multi-cancer early detection (MCED) blood test for early detection of more than 50 types of cancer. The study, SYMPLIFY, is also open at Oxford University Hospitals (OUH) and already includes more...
Inspired by Airbnb, Hims & Hers offers 10,000 free medical visits to displaced Afghan refugees
Our portfolio company, Hims & Hers, is in the process of distributing 10,000 free primary care and mental health visits to displaced Afghan refugees. According to a post on the company blog, Hims & Hers plans to coordinate with select non-governmental...
AllStripes Raises $50 million to support rare disease research
AllStripes recently closed a $50 million Series B funding round led by Lux Capital, with participation from McKesson Ventures, JAZZ Venture Partners, Spark Capital, Medidata Solutions (a Dassault Systèmes company), and Maveron, along with angel investors including...
Investors Pouring Billions into Digital Health Ventures
As COVID-19 has caused a sea change in healthcare, with the rapid expansion of virtual healthcare and telemedicine, investors have been busy pouring their dollars into the digital health space. In fact, between January and June of 2021, almost $15 billion in funding...
Meet Michelle Snyder, partner at McKesson Ventures
While there are more startups than ever, there’s also more money chasing them than ever. Vator News is profiling key members of the investment community to help companies understand what investors are looking for and how they can help startups to scale. In this...